semaglutide weight regain after stopping Many Patients Maintain Loss a Year and Liraglutide Semaglutide (Wegovy) for Weight Loss:

That could push Lilly and Novo to compete even more aggressively on price to preserve access, or expand direct-to-employer agreements that can secure lower prices for covered drugs than what the PBM model dictates

The Phase 3 success removes scientific risk, but not commercial risk

Plenty of patients do beautifully on semaglutide, and the higher number doesn't automatically make tirzepatide the right pick for you, which is exactly why the consultation matters

Common adverse effects include gastrointestinal symptoms, which affect the majority of patients to varying degrees: Nausea (20-44% of patients) usually most pronounced during dose escalation Diarrhea (20-30%) Constipation (15-24%) Vomiting (9-24%) Abdominal pain (6-10%) These symptoms typically diminish over time as physiological adaptation occurs

The extensive food library allows you to log almost anything